CYP1A1 and breast cancer: A previous study in breast cancer MCF-7 cells showed that activation of AhR/CYP1A1 increased the chemoresistance by activating the Wnt/β-catenin and ALDH pathways [8], pathways that mediate CSCs development, maintenance, and self-renewal [29].